Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells
<p>Abstract</p> <p>Background</p> <p>Histone deacetylase inhibitors (HDACi) are a new class of promising anti-tumour agent inhibiting cell proliferation and survival in tumour cells with very low toxicity toward normal cells. Neuroblastoma (NB) is the second most common...
Main Authors: | Nardou Katya, Bourloud Katia, Flahaut Marjorie, Meier Roland, Mühlethaler-Mottet Annick, Joseph Jean-Marc, Gross Nicole |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-06-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/7/1/55 |
Similar Items
-
Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio
by: Meier Roland, et al.
Published: (2006-08-01) -
Functional Sphere Profiling Reveals the Complexity of Neuroblastoma Tumor-Initiating Cell Model
by: Aurélie Coulon, et al.
Published: (2011-10-01) -
The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
by: Roland Meier, et al.
Published: (2007-01-01) -
The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
by: Annick Mühlethaler-Mottet, et al.
Published: (2015-01-01) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)